CHEMBIO DIAGNOSTICS, INC. — Revenue by Fiscal Year
13 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/9fef27a9-839b-4197-848c-f6e9084c1f8c/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2022 | $49.5M | 2022-01-01 – 2022-12-31 | evidence 0001140361-23-014526 |
| FY 2021 | $47.8M | 2021-01-01 – 2021-12-31 | evidence 0001140361-22-007735 |
| FY 2020 | $32.5M | 2020-01-01 – 2020-12-31 | evidence 0001140361-21-008210 |
| FY 2019 | $34.5M | 2019-01-01 – 2019-12-31 | evidence 0001140361-20-005780 |
| FY 2018 | $34.6M | 2018-01-01 – 2018-12-31 | evidence 0001140361-19-020057 |
| FY 2017 | $25.2M | 2017-01-01 – 2017-12-31 | evidence 0001140361-19-020057 |
| FY 2016 | $17.9M | 2016-01-01 – 2016-12-31 | evidence 0001092662-17-000023 |
| FY 2015 | $24.3M | 2015-01-01 – 2015-12-31 | evidence 0001092662-16-000121 |
| FY 2014 | $27.6M | 2014-01-01 – 2014-12-31 | evidence 0001092662-15-000024 |
| FY 2013 | $29.5M | 2013-01-01 – 2013-12-31 | evidence 0001092662-14-000018 |
| FY 2012 | $25.6M | 2012-01-01 – 2012-12-31 | evidence 0001092662-13-000024 |
| FY 2011 | $19.4M | 2011-01-01 – 2011-12-31 | evidence 0001092662-12-000013 |
| FY 2010 | $16.7M | 2010-01-01 – 2010-12-31 | evidence 0001092662-12-000013 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
CHEMBIO DIAGNOSTICS, INC. — all facts · Net Income · Operating Income